Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs

NCT00494767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Obesity

Interventions

DRUG: GW869682
DRUG: GSK189075
DRUG: GSK189075-Placebo
DRUG: GW869682-Placebo

Sponsor

GlaxoSmithKline